European Markets for Critical Care Patient Monitoring Products

For the purposes of this report, the segments comprising the European markets forcritical care patient monitoring devices include vital signs monitoring systems,neurologic monitoring systems, level of consciousness (LOC) monitoring systems,and hemodynamic monitoring systems.

In 2007, these market segments had a combined value of $1,434.9 million, with vital signs monitoring products contributing $1,182.6 million (82.4% of sales), LOCmonitoring products contributing $127.2 million (8.9% of sales), hemodynamic monitoring products contributing $88.2 million (6.1% of sales), and neurologicmonitoring products contributing $36.9 million (2.6% of sales). During the forecastperiod covered by this report, combined sales of these segments are projected toincrease at a healthy compound annual rate of 8.8%, reaching an estimated $2,191.4 million in the year 2011. The LOC monitoring segment is expected to grow the most rapidly over the forecast period (at 13.2%), followed by the vital signs monitoring segment (at 11.8%), the neurologic monitoring segment (at 4.2%), andthe hemodynamic monitoring segment (at 1.7%).